These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29412808)

  • 21. Serum prolactin levels in Behçet's disease.
    Apaydin KC; Duranoglu Y; Ozgürel Y; Saka O
    Jpn J Ophthalmol; 2000; 44(4):442-5. PubMed ID: 10974304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between circulating prolactin levels and psoriasis and its correlation with disease severity: a meta-analysis.
    Lee YH; Song GG
    Clin Exp Dermatol; 2018 Jan; 43(1):27-35. PubMed ID: 28940303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
    Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
    Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
    Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
    J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between eNOS polymorphisms and susceptibility to Behcet's disease: a meta-analysis.
    Lee YH; Song GG
    J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1266-71. PubMed ID: 21957880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum prolactin levels in Behçet's Syndrome.
    Keser G; Oksel F; Ozgen G; Aksu K; Doganavsargil E
    Clin Rheumatol; 1999; 18(4):351-2. PubMed ID: 10468181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
    Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
    Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease.
    Çerçi P; Altıner S; İnal A; Köse K; Keskin G; Ölmez Ü
    Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
    Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum prolactin levels and Behçet disease.
    Proença H; Ferreira C; Miranda M; Castanheira-Dinis A; Monteiro-Grillo M
    Eur J Ophthalmol; 2007; 17(3):404-7. PubMed ID: 17534824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum salusin-α and salusin-β levels in patients with Behcet's disease.
    Erden I; Demir B; Uçak H; Cicek D; Dertlioğlu SB; Aydin S
    Eur J Dermatol; 2014; 24(5):577-82. PubMed ID: 25115151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease.
    Şahin E; Karaman G; Uslu M; Karul A; Şendur N; Şavk E
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1498-502. PubMed ID: 22035239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.
    Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP
    Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
    Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
    Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid peroxidation and homocysteine levels in Behçet's disease.
    Mungan AG; Can M; Açikgöz S; Eştürk E; Altinyazar C
    Clin Chem Lab Med; 2006; 44(9):1115-8. PubMed ID: 16958606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.
    Erdem F; Gündoğdu M; Kiki I; Ali Sari R; Kiziltunç A
    Rheumatol Int; 2005 Oct; 25(8):599-603. PubMed ID: 15257411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.